English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Objective : A hospital based prospective observational study was done at a tertiary care hospital over a period of six month to analyse the clinically relevant co-morbidities, and quality of life in COPD patients. Methods : The study included a total of 85 COPD patients who met the inclusion criteria and the proportion of comorbidities were assessed from the inpatient case records and Quality Of Life(QOL) was assessed using St. George Respiratory Questionnaire for COPD(SGRQ-C). Result : The most common co-morbidities were Hypertension 55(64.7%), Diabetes mellitus 32(37.6%), Coronary Artery Disease 23(27.1%) and other heart disease 13 (15.3%). The least common co-morbidities were Tuberculosis 2 (2.4%), Osteoporosis 1(1.2%) and DVT 1 (1.2%) etc. In quality of life, the mean symptom score was found to be 62.1 with standard deviation of 19.3, mean activity score was found to be 71.7 with the standard deviation of 19.7 and mean impact score was found to be 52.6 with the standard deviation of 17.8 .The mean overall quality of life score was found to be 59.3 with the standard deviation of 15.9. Conclusion : It was observed that the clinically relevant co-morbid condition often coexisted in exacerbated COPD patients and had a moderate quality of life.The diagnosis and management of co-morbidities is an important challenge for the COPD patient as it is not always easy to diagnose the coexisting illness. Thus, systematic research of co-morbidities seems to be of interest. Thereby improving the medication adherence and addressing the comorbid conditions we can improve the quality of life as well as reduce the mortality and morbidity in COPD patients.

A STUDY ON PROPORTION OF COMORBIDITIES AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN A TERTIARY CARE HOSPITAL